NCT06526312 Primary Care Evidence-based Approach for Improving Lifelong Health
| NCT ID | NCT06526312 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Clinical Trial |
| Study Type | INTERVENTIONAL |
| Enrollment | 840 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 840 participants in total. It began in 2025-06-09 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the implementation and effectiveness of the Family Check-Up 4 Health (FCU4Health) intervention in primary care settings for reducing cardiovascular disease risk in children. Through a hybrid type 3 cluster randomized factorial trial and innovative technology-based strategies integrated with Electronic Health Records, the study aims to enhance intervention fidelity and engagement. Results will inform scalable approaches to promote child and family health behaviors, improve parenting skills, and potentially reduce child BMI, contributing to significant public health impacts in addressing cardiovascular health disparities.
Eligibility Criteria
Inclusion Criteria: * BMI at or above 85 percentile for age and gender. Exclusion Criteria: * N/A
Contact & Investigator
Cady Berkel, Ph.D.
PRINCIPAL INVESTIGATOR
Arizona State University
Frequently Asked Questions
Who can join the NCT06526312 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 99 Years, studying Clinical Trial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06526312 currently recruiting?
Yes, NCT06526312 is actively recruiting participants. Contact the research team at michele.porter@asu.edu for enrollment information.
Where is the NCT06526312 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT06526312 clinical trial?
NCT06526312 is sponsored by Arizona State University. The principal investigator is Cady Berkel, Ph.D. at Arizona State University. The trial plans to enroll 840 participants.